Picture of Asep Medical Holdings logo

ASEP Asep Medical Holdings Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-24.85%
3m-35.58%
6m-43.02%
1yr-50.89%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-72.32%
50d MA-10.2%
200d MA-37.29%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-40.34%
Return on Equity-56.48%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Asep Medical Holdings EPS forecast chart

Profile Summary

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    January 20th, 2021
    Public Since
    November 22nd, 2021
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    ca flag iconCanadian Securities Exchange
    Shares in Issue
    74,180,828

    ASEP Share Price Performance

    Similar to ASEP

    Picture of Albert Labs International logo

    Albert Labs International

    ca flag iconCanadian Securities Exchange

    Picture of Algernon Pharmaceuticals logo

    Algernon Pharmaceuticals

    ca flag iconCanadian Securities Exchange

    Picture of Alpha Cognition logo

    Alpha Cognition

    ca flag iconCanadian Securities Exchange

    Picture of Awakn Life Sciences logo

    Awakn Life Sciences

    ca flag iconCanadian Securities Exchange

    Picture of BetterLife Pharma logo

    BetterLife Pharma

    ca flag iconCanadian Securities Exchange

    FAQ